Starting a Veterinary Practice from Scratch: De Novo Startup Costs & Financing (2026)

Building a vet practice from the ground up is a fundamentally different financial bet than buying an existing one. You're not paying for a proven cash flow stream — you're financing a location hypothesis, a brand, and 18-24 months of ramp time. Here's the real math behind that decision.

De novo vs. acquisition: the financial trade-off

The fundamental difference is cash flow timing. When you buy an existing practice doing $1.2M in collections, you have revenue from day one — clients don't disappear because ownership changed. When you build from scratch, you have zero clients, zero revenue, and full overhead from the day you open your doors.

If you need stable income immediately or have significant personal obligations (student loans, family, existing mortgage), acquisition almost always wins year 1. If you have runway, a clear geographic opportunity, and a service differentiator, de novo can win significantly by year 5.

Startup cost breakdown: what it actually costs to open a vet practice

The biggest variable in startup costs is whether you're leasing an existing space (build-out only) or building or buying a building from scratch. Below assumes a lease of a commercial shell space for a 2,000-sq-ft small-animal general practice in a suburban market.

Financing a de novo vet practice: what's available in 2026

SBA 7(a) loans for startup practices

SBA 7(a) loans are available for de novo vet practices, but the underwriting is materially different from acquisition financing. Without historical cash flow, lenders underwrite against:

• Your personal credit (700+ preferred; minimum 680)
• Market analysis — population density, pet household penetration, competitive landscape
• Your clinical experience (lenders want 3+ years post-graduation)
• A detailed business plan with 3-year financial projections
• Personal liquidity beyond the down payment (lenders want to see you can survive the ramp)

Because projections can't prove DSCR the way historical financials can, SBA lenders typically require 15–20% equity injection for de novo practices vs. 10–25% for acquisitions. Current rates (2026): SBA 7(a) cap is prime + 2.75% = 9.50% for loans over $350K. Most de novo borrowers see 9.0–9.5% on 10-year terms.

Specialized vet lenders for de novo: Live Oak Bank and US Bank Practice Finance have dedicated veterinary lending teams that understand the de novo ramp curve better than generalist SBA lenders. They're more likely to approve a well-structured startup application and close in 45–90 days.

Equipment financing (separate from your SBA loan)

Diagnostic and surgical equipment can often be financed separately through equipment lenders at rates of 6–9% over 3–7 years, using the equipment itself as collateral. This has two advantages for a de novo startup:

1. It reduces the total you need to borrow under your SBA 7(a) loan, improving your application's odds
2. It preserves the ability to use Section 179 ($2.56M limit, 2026) and OBBBA 100% bonus depreciation on the full equipment cost in year 1, even when financed

At $175K of equipment financed over 5 years at 7.5%: monthly payment ~$3,500. Compare that to expensing the full $175K via Section 179 in year 1 — creating a $175K deduction against any other income you have that year.

SBA 504 loans for de novo + building purchase

If you're buying or building your own facility (not leasing), SBA 504 adds a third financing structure:

• 50% conventional first mortgage from a bank
• 40% Certified Development Company (CDC) loan (SBA-backed, fixed rate)
• 10% your equity injection

2026 CDC fixed rates: approximately 6.7–7.5% (20-year term). If your build-out is permanent and you want long-term building ownership, this structure can be more efficient than pure SBA 7(a). See the full analysis in our vet practice real estate guide.

Year 1–3 cash flow: what the ramp really looks like

A realistic small-animal de novo ramp in a solid suburban location:

The working capital math: If you're averaging -$15,000/month cash deficit for 18 months, that's $270,000 in cumulative negative cash flow before you break even. That's why experienced vet startup lenders and CFPs recommend $150,000–$250,000 in working capital reserve, on top of your equipment and build-out capital. The practices that fail aren't usually undercapitalized on the equipment side — they run out of operating runway.

Entity structure and tax timing for a new practice

PLLC vs. PC: which professional entity to use

Most states require veterinarians to practice under a Professional Limited Liability Company (PLLC) or Professional Corporation (PC) — only licensed DVMs can own equity. Check your state's veterinary board rules before incorporating. A general LLC typically cannot hold a vet practice license.

S-corp election: the 75-day window

Once you've incorporated your PLLC or PC, you have a limited window to elect S-corporation taxation under IRC §1362. For a new entity: the election must be filed within 2.5 months (75 days) of your incorporation date to apply to your first tax year. Miss that window and you wait until the following calendar year.

However, in a de novo startup year 1, your practice may operate at a net loss — in which case the S-corp election saves you nothing on self-employment tax that year. Many DVMs starting de novo elect S-corp from inception anyway (so you don't miss the window) but don't bother with formal payroll until the practice generates consistent positive income. Work with your CPA on the specific timing. See the S-corp election guide for the full savings analysis once you're profitable.

Solo 401(k): set it up before you hire your first employee

A Solo 401(k) is available to self-employed individuals with no W-2 employees (other than a spouse). In 2026, the combined employee + employer contribution limit is $72,000 ($24,500 employee deferral + employer profit sharing up to 25% of net SE income, capped at $72K total).

Once you hire your first W-2 staff member, the Solo 401(k) must be terminated and converted to a group plan. For a de novo practice, you often have several months operating as a solo DVM (owner only) before hiring support staff. Set up the Solo 401(k) immediately — even if you contribute little in year 1, having it in place means you don't lose the structure when year 2 income arrives.

Year-1 tax losses: an underused de novo benefit

Your practice will likely generate a net operating loss in year 1. Under current rules, de novo startup costs can be deducted as follows:

• Section 195 organizational costs: First $5,000 of startup costs (legal fees, state filing fees) deducted immediately; remainder amortized over 180 months
• Section 179 + OBBBA 100% bonus depreciation: All equipment placed in service year 1 can be fully expensed, creating a large deduction that may exceed your first-year income and produce a net operating loss
• Net operating loss carryforward: Losses in year 1 carry forward indefinitely (80% of future taxable income limit) to offset profitable future years

If you have a working spouse with W-2 income, structuring a year-1 practice loss that flows through to your joint return can produce a meaningful tax refund — partially offsetting the negative cash flow pain of the ramp period. This requires the practice to be organized as a pass-through entity (PLLC taxed as sole proprietorship or S-corp, not C-corp).

Equipment: buy vs. lease the financial analysis

For de novo practices, the buy vs. lease decision on major equipment usually comes down to two factors: cash conservation and tax strategy.

The tax case for buying: A $175,000 equipment purchase in year 1 creates a $175,000 deduction via Section 179 — regardless of whether you financed it. If you're in the 32% bracket (net income from spouse's income, for example), that's a $56,000 tax savings while your monthly loan payment is only ~$3,500. You can't replicate that with an operating lease.

Location economics: the numbers a site needs to support

Corporate groups (VCA, NVA, BluePearl, Mars) have sophisticated site-selection teams. A de novo DVM operating solo doesn't have their resources, but the core economics are straightforward:

• Pet households within 3 miles: A small-animal clinic needs ~3,000–5,000 pet-owning households to realistically build a 2,000+ active client base over 3 years. U.S. pet ownership rate is ~70% of households.
• Revenue target: At $500 average annual spend per active client × 2,000 clients = $1M annual collections. That's a reasonable 5-year target for a well-located single-DVM practice.
• Competition density: Corporate groups dominate urban cores. Look for established suburbs that are underserved — areas where the nearest vet has a 3–6 week wait for new-client appointments are your opportunity.
• Demographics: Median household income $75K+ significantly increases per-visit spend and willingness to pursue diagnostics and specialist referrals.

Your SBA lender (especially Live Oak or US Bank Practice Finance) will often do their own market analysis as part of underwriting. If they flag your chosen location as oversaturated, take it seriously — they've seen many de novos fail and succeed, and their site analysis is worth reviewing even if you disagree.

Worked example: opening a 2,000-sq-ft small-animal practice

A DVM with 4 years associate experience, $85K in savings, FICO 720, and a leased shell space in a suburban market.

Financing structure:

• SBA 7(a) loan: $445,000 (84% of total, within SBA guidelines given personal assets)
• Equity injection: $85,000 (16% — all personal savings)
• Monthly SBA payment (10yr at 9.25%): ~$4,650/month ($55,800/yr)

Year 1 tax outcome: Equipment (build-out treated as leasehold improvement, amortized 15 years; equipment $165K expensed via Section 179 and OBBBA bonus depreciation). Combined with operating loss from below-overhead revenue, first-year deductions likely produce a NOL that carries forward into the profitable years 2–4.

When de novo makes financial sense

A de novo is the right financial choice when:

1. You have runway beyond the down payment. 18–24 months of living expenses separate from startup capital. If you're counting on practice revenue to pay your rent by month 6, build in more reserve or reconsider the acquisition path.
2. You've identified a genuinely underserved market. Not "this area seems nice" — specific evidence: nearest competitor has waitlists, no new clinic in 3 years, population growing.
3. You want clinical control you can't buy. You want to build a low-stress, fear-free, or exotic-focused practice model that existing practices won't do. The premium you pay in ramp time buys you a culture and systems that can't be retrofitted into an acquired practice.
4. Acquisition multiples are too high in your market. In some markets, good practices are selling at 90–95% of collections. At those prices, de novo can be cheaper per EBITDA dollar within 5 years.
5. You plan a corporate exit in 8–12 years. Corporate consolidators (Mars, NVA, MVP) often pay higher multiples for clean, systems-driven de novo practices than for practices with legacy equipment, inherited client quirks, and years-old management. A practice built with a corporate exit in mind — digital records from day one, multiple revenue streams, strong new-client growth — can be worth more at a 10–12× multiple than an acquisition you bought at 8× and ran for a decade.

What to do before you sign a lease

1. Talk to a specialized vet financial advisor and a vet lender simultaneously. Not a generalist — a CPA or CFP who works with practice owners and a lender (Live Oak, US Bank) who has closed de novo vet deals. Do this 12 months before you plan to open, not 60 days before.
2. Run 3 cash flow scenarios: base case, slow-ramp (ramp takes 6 months longer), and fast-ramp. Your loan and working capital need to survive the slow-ramp scenario.
3. Negotiate your lease carefully. An abatement period (3–6 months of free rent) is standard for shell-space build-outs and can materially help year-1 cash flow. Have your attorney review the CAM charges, tenant improvement allowance, and landlord's remediation obligations.
4. Set up your PLLC/PC and elect S-corp within 75 days of incorporation. Don't scramble on entity structure after you've already signed the lease.
5. Pre-order your DEA registration early. Registration takes 4–6 weeks and you can't legally dispense controlled substances (opioid pain management, euthanasia solutions) without it. Many practices have had to delay opening due to DEA timing.